33.7 C
New York
Friday, June 12, 2026

Tag: Entrepreneurship

newssourceFORcompanyinformationcontent1marketreleases

Space Fiesta 2025 Lights Up Albuquerque with Innovation, Art, and Economic Momentum

ALBUQUERQUE, N.M., June 26, 2025 /PRNewswire/ -- Space Fiesta 2025, the highly anticipated fusion of science, technology, entrepreneurship and creative culture in the space...

UNIVERSAL MUSIC GROUP NAMED TO TIME’S 2025 LIST OF THE 100 MOST INFLUENTIAL COMPANIES

UMG's inclusion in the TIME100 marks the first appearance of a major music company since the list's inception SANTA MONICA, Calif., June 26, 2025...

Tech Startup Detonates Twitter HQ Sign

Ditchit makes a bold statement in the online marketplace space with an explosive launch event detonating the iconic 12 foot 560 pound Twitter HQ sign

Kiddie Academy® of New Lenox now under new ownership

Local entrepreneurs operating second Chicago-area Academy location NEW LENOX, Ill., June 26, 2025 /PRNewswire/ -- Kelly Harper and Chris Grahn, owners of Kiddie Academy® of Lemont,...

Municipal government per-person spending in Canada hit near record levels

VANCOUVER, BC, June 26, 2025 /CNW/ - Municipal government spending in Canada hit near record levels in recent years, finds a new study by...

Bezos Wedding in Venice—Evaluating Impacts on Luxury Market Trends

Venice recently became the backdrop for an event that underscores the intersection of modern commerce and historical opulence, as Jeff Bezos and Lauren Sánchez...

Craft Telemedicine Launches to Redefine Specialty Care with Human-Centered Platform

Revolutionary no-subscription telemedicine model gives patients complete control over specialized compounded medications and pharmacy choice. TULSA, Okla., June 25, 2025 /PRNewswire/ -- Craft Telemedicine today...

Atlanta Beltline Celebrates New Addition to Westside Trail, Creating the Longest Continuous Trail in Corridor

The 1.3-mile Westside Trail–Segment 4 project connects communities from Pittsburgh Yards to Blandtown, delivering 6.7 miles of uninterrupted pathway alongside historic Washington Park ATLANTA, June...

Daymond John Gives Shout-Out to Wisdom Senior Care at IFA World Franchise Show

Franchise brand receives spotlight recognition from "Shark Tank" star during debut exhibit at global franchising event MIAMI, June 25, 2025 /PRNewswire/ -- Wisdom Senior Care, a growing in-home senior care franchise based...

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

White House Tech Leaders Threaten Innovation—Evaluating Long-Term Investment Risks

The role of American universities in driving entrepreneurial success is indisputable, particularly in their contribution to foundational technologies and medical advancements. This direct link...

Accountability Names Judd Rubin Chief Executive Officer

Strategic leadership transition positions purpose-built financial platform for continued growth and innovation NEW YORK, June 23, 2025 /PRNewswire/ -- Accountability, the leading cloud-based financial management...

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEntrepreneurship

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers